Selected article for: "lung disease and patient population"

Author: Dayco, John S.; El-Reda, Zeinab; Sumbal, Nabeel; Alhusain, Rashid; Raheem, Shaheena
Title: Perpetually Positive: Post-COVID Interstitial Lung Disease in an Immunocompromised Patient With Diffuse Large B-cell Lymphoma
  • Cord-id: c251foly
  • Document date: 2021_8_24
  • ID: c251foly
    Snippet: As more patients recover from COVID-19 infection, long-term complications are beginning to arise. Our case report will explore a debilitating long-term complication, Post-COVID Interstitial Lung Disease (PC-ILD). We will introduce a patient who developed PC-ILD in the setting of diffuse large B-cell lymphoma, outlining a difficult hospital course, including a positive COVID-19 polymerase chain reaction (PCR) for more than 3 months. We will then discuss the human body’s physiological response t
    Document: As more patients recover from COVID-19 infection, long-term complications are beginning to arise. Our case report will explore a debilitating long-term complication, Post-COVID Interstitial Lung Disease (PC-ILD). We will introduce a patient who developed PC-ILD in the setting of diffuse large B-cell lymphoma, outlining a difficult hospital course, including a positive COVID-19 polymerase chain reaction (PCR) for more than 3 months. We will then discuss the human body’s physiological response to the virus and how our patient was not able to adequately mount an immune response. Finally, the pathophysiology of PC-ILD will be explored and correlated with the patient’s subsequent computed tomographic images obtained over a 3-month period. The difficult hospital course and complex medical decision-making outlined in this case report serve as a reminder for health care providers to maintain vigilance in protecting our most vulnerable patient population from such a devastating disease process.

    Search related documents:
    Co phrase search for related documents
    • absolute alc lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and adequate treatment: 1, 2
    • active infection and adequate treatment despite: 1
    • active infection and long term complication: 1
    • active infection and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • active infection and lung parenchyma: 1, 2
    • active infection and lymphocyte count: 1, 2, 3
    • adequate treatment and lung disease: 1, 2, 3, 4, 5
    • adequate treatment and lung parenchyma: 1, 2
    • adequate treatment despite and lung disease: 1
    • adequate treatment despite and lung parenchyma: 1
    • low grade breath and lymphocyte count: 1
    • low remain and lung disease: 1